Patients with spinal cord injuries and other forms of paralysis have reason to be optimistic, thanks to recent advances in the use of spinal-cord stimulator devices to regain some lower limb function. A recently announced study reporting ...
Mad Dogg Athletics, Inc., (MDA) parent company of Spinning, Peak Pilates, Bodyblade, Ugi and Resist-A-Ball, has signed an exclusive worldwide license agreement with CrossCore, Inc., the leader in rotational bodyweight training products and ...
Tags: Sporting Goods, Recreation
Landec Corporation, a materials science company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, is expanding commercial applications for its patented BreatheWay ...
US-based materials science company Landec is all set to expand commercial applications for its BreatheWay technology packaging solutions. The technology has been developed to optimize the ratio of carbon dioxide and oxygen within the ...
Tags: Landec, Breatheway Packaging
Johnson & Johnson's Janssen Biotech Inc. is showing interest in stem cell therapy delivered to the heart via a catheter. Janssen is providing an upfront payment of $12.5 million related to Capricor Therapeutics Inc.'s CAP-1002 therapy ...
Tags: Janssen, Catheter, Stem Cell Tech
Rocksource ASA ("Company" & "Rocksource") hereby announces that the Company has entered into agreements with the Norwegian branch of a European oil and gas company related to sale of electromagnetic data (EM data) and licensing of ...
Tags: Rocksource, electromagnetic data, Rocksource Discover software
Braskem and Genomatica announced an agreement for the joint development of commercial process technology to make bio-based butadiene from renewable feedstocks. Braskem is the world's leading producer of biopolymers and the world's third ...
Tags: Braskem, Genomatica, bio-based butadiene, renewable feedstocks
The US Food and Drug Administration (FDA) has granted orphan drug status for Kinex Pharmaceuticals' dual src/pre-tubulin inhibitor 'KX02' for the treatment of gliomas, which are the most common and aggressive form of brain cancer. KX02 is ...
Tags: Orphan Drug, Medicine
MagneMotion, a provider of products and transport systems based on Linear Synchronous Motor (LSM) technology, has announced a strategic partnership with Siemens Healthcare Diagnostics, whereby Siemens has acquired an exclusive license for ...
US-based specialty pharmaceutical firm Impax Laboratories (Impax) has started shipment of generic Solaraze (diclofenac sodium gel, 3%), a first-to-file product, through its generics division Global Pharmaceuticals. In order to ...
Viteava Pharmaceuticals has announced the execution of an exclusive worldwide license to an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, ...
Tags: exclusive worldwide license, EGCG, Viteava Pharmaceuticals
Alphaeon, a wholly-owned subsidiary of Strathspey Crown Holdings, has acquired an exclusive US license from Schwind eye-tech solutions to market the AMARIS excimer laser system, for an undisclosed amount. The laser system, launched in ...
Tags: Alphaeon, Vision Correction
As part of a new strategic initiative, aimed at strengthening its presence in cranberry derivatives, Indena has entered an industrial and commercial agreement with Pharmatoka. On the basis of this agreement, Indena will produce Gikacran ...
Tags: Cranberry Extract
US-based pharmaceutical firm Zogenix has entered into a development and option agreement (D&O Agreement) with Altus Formulation (Altus) to develop abuse deterrent formulations of Zohydro ER (hydrocodone bitartrate) extended-release ...
Tags: Zogenix, Zohydro ER
Fidelity Biosciences, a subsidiary of Fidelity Investments, and US-based Regenx Biosciences have announced the formation of Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases. Dimension ...
Tags: Biosciences, Health, Medicine